Cue BioPharma
CUE18.95011.21% ( +1.910 )
已收盤: 10月21日 16:00:01 (美東)全部股東
股東類型
- 公眾及其他64.76%
- 機構投資者22.80%
- 個人與內幕人士7.34%
- 對沖基金5.10%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Shao-Lee LinPresident, CEO & Director | 5.34% | 38.78 萬 | 0.92% | +6.03 萬 | |
Bleichroeder LP | 5.10% | 37.07 萬 | 1.88% | +14.34 萬 | 30/06/2026 |
Strome Investment Management, L.P. | 5.10% | 37.04 萬 | 4.09% | +31.78 萬 | 14/07/2026 |
Driehaus Capital Management LLC | 4.02% | 29.21 萬 | -- | +29.21 萬 | 30/06/2026 |
Vanguard Capital Management, LLC | 2.56% | 18.62 萬 | 0.51% | +8.61 萬 | 30/06/2026 |
Ikarian Capital, LLC | 1.44% | 10.44 萬 | -- | +10.44 萬 | 30/06/2026 |
Tetragon Partners UK LLP | 1.29% | 9.38 萬 | -- | +9.38 萬 | 30/06/2026 |
StemPoint Capital LP | 0.92% | 6.70 萬 | -- | +6.70 萬 | 30/06/2026 |
Sumita RayChief Legal & Compliance Officer and Corporate Secretary | 0.90% | 6.55 萬 | 0.14% | +1.09 萬 | |
BlackRock, Inc. | 0.80% | 5.78 萬 | 0.34% | +4.28 萬 | 30/06/2026 |
ADAR1 Capital Management, LLC | 0.76% | 5.52 萬 | -- | +5.52 萬 | 30/06/2026 |
Lion Point Capital, LP | 0.73% | 5.29 萬 | 1.53% | -2.05 萬 | 30/06/2026 |
Mark Strome | 0.71% | 5.17 萬 | 0.58% | +4.46 萬 | 14/07/2026 |
Squadron Capital Management LLC | 0.69% | 5.00 萬 | -- | +5.00 萬 | 30/06/2026 |
Diadema Partners LP | 0.67% | 4.84 萬 | 0.53% | +4.40 萬 | 30/06/2026 |
Geode Capital Management, LLC | 0.66% | 4.78 萬 | 0.43% | +1.23 萬 | 30/06/2026 |
Boothbay Fund Management, LLC | 0.43% | 3.15 萬 | 0.43% | +3.15 萬 | 30/06/2026 |
UBS Asset Management AG | 0.37% | 2.67 萬 | 0.28% | +2.38 萬 | 30/06/2026 |
Citadel Advisors LLC | 0.35% | 2.56 萬 | -- | +2.56 萬 | 30/06/2026 |
Texas Capital Bank Wealth Management Services, Inc. | 0.31% | 2.29 萬 | 0.09% | +9,634.00 | 30/06/2026 |